Advanced search
Publication Cover
Current Medical Research and Opinion Volume 20, 2004 - Issue 7
Submit an article Journal homepage
41
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Effect of raloxifene on the incidence of elevated low density lipoprotein (LDL) and achievement of LDL target goals in postmenopausal women

David A. Cox Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USACorrespondence[email protected]
,
Somnath Sarkar Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
,
Kristine Harper Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
&
Elizabeth Barrett-Connor University of California, San Diego, La Jolla, CA, USA
Pages 1049-1055 | Accepted 28 Apr 2004, Published online: 21 May 2004

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yukari Uemura, Teruki Sone, Shiro Tanaka, Teruhiko Miyazaki, Mayumi Tsukiyama, Akira Taguchi, Satoshi Soen, Satoshi Mori, Hiroshi Hagino, Toshitsugu Sugimoto, Masao Fukunaga, Hiroaki Ohta, Toshitaka Nakamura, Hajime Orimo & Masataka Shiraki. (2020) Randomized head-to-head comparison of minodronic acid and raloxifene for fracture incidence in postmenopausal Japanese women: the Japanese Osteoporosis Intervention Trial (JOINT)-04. Current Medical Research and Opinion 36:11, pages 1847-1859.
Read now
Ivan P Uray & Powel H Brown. (2006) Prevention of breast cancer: current state of the science and future opportunities. Expert Opinion on Investigational Drugs 15:12, pages 1583-1600.
Read now

Articles from other publishers (5)

Jing Yu, Masato Eto, Masahiro Akishita, Tetsuro Okabe & Yasuyoshi Ouchi. (2009) A selective estrogen receptor modulator inhibits TNF-α-induced apoptosis by activating ERK1/2 signaling pathway in vascular endothelial cells. Vascular Pharmacology 51:1, pages 21-28.
Crossref
Jing Yu, Masato Eto, Koichi Kozaki, Masahiro Akishita, Tetsuro Okabe & Yasuyoshi Ouchi. (2008) Raloxifene analogue LY117018 suppresses oxidative stress-induced endothelial cell apoptosis through activation of ERK1/2 signaling pathway. European Journal of Pharmacology 589:1-3, pages 32-36.
Crossref
FELICIA COSMAN & ROBERT LINDSAY. 2007. Treatment of the Postmenopausal Woman. Treatment of the Postmenopausal Woman 837 845 .
Harriet Johansson, Bernardo Bonanni, Frederique Mariette, Massimiliano Cazzaniga, Laura Baglietto, Aliana Guerrieri-Gonzaga, Maria Teresa Sandri, Alberto Luini, Giuseppe Pelosi & Andrea Decensi. (2006) Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer. Breast Cancer Research and Treatment 98:2, pages 167-172.
Crossref
Chad L DealMichael W Draper. (2016) Raloxifene: A Selective Estrogen-Receptor Modulator for Postmenopausal Osteoporosis – a Clinical Update on Efficacy and Safety. Women's Health 2:2, pages 199-210.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.